Early use of high-efficacy disease‑modifying therapies makes the difference in people with multiple sclerosis: an expert opinion

Multiple sclerosis (MS) is a chronic and progressive neurological disease that is characterized by neuroinflammation, demyelination and neurodegeneration occurring from the earliest phases of the disease and that may be underestimated. MS patients accumulate disability through relapse-associated wor...

Descripción completa

Detalles Bibliográficos
Autores principales: Filippi, Massimo, Amato, Maria Pia, Centonze, Diego, Gallo, Paolo, Gasperini, Claudio, Inglese, Matilde, Patti, Francesco, Pozzilli, Carlo, Preziosa, Paolo, Trojano, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489547/
https://www.ncbi.nlm.nih.gov/pubmed/35608658
http://dx.doi.org/10.1007/s00415-022-11193-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489547/
https://www.ncbi.nlm.nih.gov/pubmed/35608658
http://dx.doi.org/10.1007/s00415-022-11193-w

Ejemplares similares